Anthropic AI Selloff Hits European Software Stocks

Anthropic AI selloff after posting an agentic legal-team tool erased $285.0 billion across software and data stocks and tightened trader positioning.

February 04, 2026·2 min read
View all news articles
Flat-vector cover showing a legal-focused AI tool motif symbolizing the Anthropic AI selloff and European software shock.

KEY TAKEAWAYS

  • Anthropic posted an agentic AI tool, triggering a broad selloff in European and Indian software and data stocks.
  • An estimated $285.0 billion in market value was erased across software, financial services and asset-management sectors.
  • RELX, LSEG and Experian fell 12.0%, 8.1% and 7.4%, reflecting rapid sector repricing.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Anthropic’s release of an agentic AI tool for corporate legal teams on February 3, 2026, triggered a sharp selloff in European and Indian software and data stocks. The move intensified investor concerns that AI could disrupt revenue streams for established professional-services firms.

Market Impact and Stock Declines

The selloff began before the U.S. market opened, erasing $285 billion in market value across software, financial-services, and asset-management sectors. FTSE 100 companies RELX PLC, London Stock Exchange Group, and Experian PLC fell 12%, 8.1%, and 7.4%, respectively, on the same day. The decline spread across software, data analytics, advertising, financial services, professional services, and other business-to-business sectors. Indian IT exporters dropped 6% on February 4, following the global software sector weakness.

Anthropic’s Funding and Competitive Pressure

In January 2026, Anthropic raised its funding-round target from $10 billion to $20 billion, aiming for a post-financing valuation of $350 billion. The round was led by Singapore’s GIC and Coatue Management and included Sequoia Capital, Microsoft, and NVIDIA. Investors cited the product release and increased fundraising as evidence of growing competitive pressure from well-capitalized AI entrants. They fear that agentic AI could automate legal research, compliance, and analytics workflows, reducing demand for legacy software and data services.

Before the selloff, RELX, Experian, and London Stock Exchange Group had already declined about 37%, 34%, and 32% from their recent peaks, reflecting ongoing valuation pressure. The simultaneous product launch and funding increase highlight Anthropic’s accelerating capital deployment and competitive positioning against OpenAI, prompting investors to sharply revalue incumbent data-services and professional-services platforms.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Micron Earnings Hit Record Q2 Results

Micron Earnings Hit Record Q2 Results

Micron earnings topped forecasts with a record Q2 and higher Q3 guidance, prompting traders to weigh upside versus heavy capex and cash-flow risk.

Cal-Maine Q3 Results Show Sales Pressure

Cal-Maine Q3 Results Show Sales Pressure

Cal-Maine Q3 results showed sales down as egg prices normalized and EPS beat while a pivot to specialty and prepared foods may steady earnings and trading

Lamb Weston Earnings Lift Guidance, Cut Capex

Lamb Weston Earnings Lift Guidance, Cut Capex

Lamb Weston earnings beat adjusted EPS and lifted FY2026 sales midpoint while cutting capex to ~$400M, shifting investor focus toward cash generation.

SpaceX IPO Files Confidential SEC Submission

SpaceX IPO Files Confidential SEC Submission

SpaceX IPO confidential filing signals a $75B raise and $1.75T target valuation that could shift capital into satellite and AI infrastructure

Lilly Foundayo FDA Approval Fuels GLP-1 Race

Lilly Foundayo FDA Approval Fuels GLP-1 Race

Lilly Foundayo FDA approval clears an oral GLP-1 that will ship via LillyDirect with low advertised pricing, accelerating access and pressuring rivals.

Beyond Meat Q4 2025 Earnings Miss, Sales Slide

Beyond Meat Q4 2025 Earnings Miss, Sales Slide

Beyond Meat Q4 2025 earnings showed weaker sales, collapsing margins and material weaknesses and set Q1 guidance, likely pressuring shares.